Boehringer Ingelheim
Recent News About Boehringer Ingelheim
-
Drug-maker wins Pradaxa lawsuit over woman's fatal GI bleed
HARTFORD, Conn. (Legal Newsline) – The maker of the blood-thinner Pradaxa has successfully fought off a lawsuit that blamed it for a Connecticut woman’s death. -
Trial lawyers start search for next big mass tort, increase Zantac ads by more than 1,000%
Recent advertising figures indicate the makers of the heartburn drug Zantac and its generic equivalents will soon be facing an onslaught of lawsuits, as personal injury lawyers have begun the process of rounding up clients.